Table 8.
Variable | T1 | T2 | T3 | Time*group | Time*group*gender |
---|---|---|---|---|---|
POMS Tension | |||||
PLA | 13 ± 4 | 13 ± 5 | 14 ± 4 | Time p = 0.09 | G*T*Ge p = 0.61 |
LD | 13 ± 3 | 14 ± 5 | 14 ± 4 | G*T p = 0.98 | |
HD | 14 ± 4 | 15 ± 4 | 15 ± 4 | ||
POMS Depression | |||||
PLA | 16 ± 3 | 16 ± 4 | 17 ± 4 | Time p = 0.12 | G*T*Ge p = 0.47 |
LD | 16 ± 2 | 17 ± 5 | 17 ± 3 | G*T p = 0.55 | |
HD | 17 ± 2 | 18 ± 6 | 17 ± 5 | ||
POMS Anger | |||||
PLA | 13.3 ± 2.4 | 13.9 ± 2.8 | 14.0 ± 3.7 | Time p = 0.50 | G*T*Ge p = 0.97 |
LD | 13.0 ± 1.8 | 13.7 ± 4.2 | 13.5 ± 3.6 | G*T p = 0.65 | |
HD | 13.7 ± 2.4 | 13.4 ± 2.1 | 13.5 ± 2.9 | ||
POMS Vigor | |||||
PLA | 22 ± 5 | 22 ± 6 | 21 ± 6 | Time p = 0.021 | G*T*Ge p = 0.044 |
LD | 23 ± 5 | 19 ± 6 † | 23 ± 6 ‡ | G*T p = 0.006 | |
HD | 21 ± 5 | 20 ± 6 | 19 ± 5 | ||
POMS Fatigue | |||||
PLA | 11 ± 3 | 12 ± 5 | 14 ± 5 | Time p = 0.031 | G*T*Ge p = 0.79 |
LD | 11 ± 4 | 12 ± 5 | 11 ± 4 | G*T p = 0.41 | |
HD | 13 ± 5 | 14 ± 5 | 15 ± 6 | ||
POMS Confusion | |||||
PLA | 12 ± 2 | 13 ± 3 | 13 ± 3 | Time p = 0.64 | G*T*Ge p = 0.22 |
LD | 13 ± 2 | 13 ± 2 | 13 ± 3 | G*T p = 0.65 | |
HD | 13 ± 3 | 14 ± 4 | 13 ± 3 | ||
POMS Total | |||||
PLA | 44 ± 13 | 45 ± 17 | 49 ± 16 | Time p = 0.023 | G*T*Ge p = 0.62 |
LD | 43 ± 10 | 50 ± 20 | 45 ± 15 | G*T p = 0.50 | |
HD | 51 ± 15 | 58 ± 23 | 58 ± 20 |
Abbreviations: PLA Placebo, LD Theacrine Low Dose, HD Theacrine High Dose, G Group, T Time, Ge Gender
Symbols: ‡, increase from corresponding T2 value within the male TC-LD group (p < 0.05); †, different from corresponding T1 value (p < 0.05). Items in bold indicate a significant effect (p < 0.05) was observed